Nevertheless, a study evaluating Chinese patients with colorectal cancer has revealed the upregulation of NETO2 in 52.6% of cases, reporting an association between expression and advanced tumor stage and invasion, poor differentiation, lymph node metastasis, and unfavorable prognosis in patients (Hu et al., 2015). This evidence concerns the gene NETO2 and colorectal cancer.